Douglas Blayney, MD, Oncology, Palo Alto, CA, Stanford Health Care

DouglasWBlayneyMD

Oncology Palo Alto, CA

Breast Cancer, Hematologic Oncology

Professor, Medicine - Oncology, Stanford University Medical Center

Dr. Blayney is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Blayney's full profile

Already have an account?

Education & Training

  • University of California San Diego
    University of California San DiegoResidency, Internal Medicine, 1977 - 1980
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 1977

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2003 - 2022
  • CA State Medical License
    CA State Medical License 1978 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FASCO) American Society of Clinical Oncologists, 2007

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Plinabulin (Plin) combined with half-dose pegfilgrastim (Peg) compared with full-dose peg alone for chemotherapy- induced-neutropenia (CIN): Neutrophil, bone pain, and... 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • Comparison of pegfilgrastim (Peg), plinabulin (Plin), and the combination for chemotherapy (Chemo) induced neutropenia (CIN) prevention: Rationale for the combination. 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • A Randomized Phase 3 Clinical Trial of the Combination of Plinabulin (plin) + Pegfilgrastim (peg) Versus (vs) Peg Alone for Tac (docetaxel, doxorubicin, cyclophosphami... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Government-Controlled Health Care Won’t Help Us Live Longer
    Government-Controlled Health Care Won’t Help Us Live LongerMarch 4th, 2020
  • Plinabulin Continues to Show Promise for Treating Chemotherapy-Induced Neutropenia
    Plinabulin Continues to Show Promise for Treating Chemotherapy-Induced NeutropeniaJanuary 17th, 2020
  • What You Need to Know About Plinabulin
    What You Need to Know About PlinabulinJanuary 11th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations